Cushing's Syndrome
Pipeline by Development Stage
Drug Modality Breakdown
On Market (3)
Approved therapies currently available
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (8)
Total enrollment: 371 patients across 8 trials
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia